Inulin, omega-3, and synbiotics: what a new inflammation study actually compared

Inflammation is one of those words that has been stretched almost to meaninglessness in wellness marketing. Almost every supplement, every diet, and every protocol claims to fight it. So when a paper drops that actually measures dozens of specific inflammatory markers across three different dietary interventions, it is worth slowing down to look at what was tested, what changed, and what the design can support.

Image by Nennieinszweidrei via Pixabay

What the research found

The study was published in October 2025 in the Journal of Translational Medicine by Dr. Amrita Vijay and colleagues at the University of Nottingham. The team ran a six-week intervention in which 104 participants were divided into four groups. The synbiotic group (n=20) received 170 milliliters of fermented kefir plus 10 grams of a prebiotic fiber mix daily. The omega-3 group (n=33) received 500 milligrams of omega-3 per day. The inulin group (n=31) received 20 grams of inulin fiber per day. The control group (n=20) received no supplementation.

Inflammation was measured using the Olink 96 inflammation panel, which profiles 96 different inflammatory proteins from a serum sample. This is a much more granular look than the usual single-marker studies that just check C-reactive protein.

All three interventions significantly reduced inflammation compared to the control group. Tumor necrosis factor alpha (TNF-alpha), a major inflammatory signaling protein, dropped in both the omega-3 group and the inulin group. The synbiotic group, however, showed broader and larger effects. Interleukin 6, interferon gamma, SIRT2, 4EBP1, CCL23, and several mucosal cytokines all came down significantly. Increases in serum butyrate, a beneficial short-chain fatty acid made by gut bacteria when they ferment fiber, correlated with the drops in interleukin 6 in the synbiotic group.

A few caveats are essential before reading too much into the synbiotic-was-best framing. The synbiotic group was the smallest, which raises questions about statistical robustness. The kefir used in the synbiotic was provided by Chuckling Goat Ltd., a UK kefir company whose founders are listed as co-authors. The study openly discloses this, but readers should weigh it. And the gut microbiome itself was not profiled in this study; the team has flagged that for future work.

The bigger picture

The signal that fiber, omega-3, and fermented foods can lower inflammation is not new. Each of those interventions has its own body of evidence. What this paper adds is a head-to-head comparison using a sensitive multi-protein platform, which is rare in nutrition research.

The synbiotic concept, combining a probiotic with a prebiotic so that the live bacteria have food to work with, is the more interesting piece. A 2024 systematic review of synbiotic interventions across inflammatory conditions, including metabolic syndrome and inflammatory bowel disease, found generally favorable signals on inflammatory markers, though the literature is still small and heterogeneous. The mechanism makes sense. Live bacteria delivered without their preferred substrate often fail to establish; fed bacteria do better.

The omega-3 finding is consistent with decades of work on fish oil and inflammation, though 500 milligrams per day is on the low end of doses typically studied. Larger doses, especially of EPA-predominant formulas, have stronger effects in some inflammatory conditions but also carry more side effect potential. The inulin result is consistent with a broader story about fermentable fibers, short-chain fatty acid production, and gut-driven systemic inflammation.

What the paper does not tell us is whether these short-term reductions in inflammatory markers translate to clinical improvement in people with actual inflammatory conditions over months or years. That is a different study.

The naturopathic lens

This is the kind of paper I find genuinely useful in clinic, even with the caveats. Most patients I see in my mast cell activation syndrome (MCAS), small intestinal bacterial overgrowth (SIBO), and chronic-inflammation populations want to know which lever to pull first. The accurate answer has always been: it depends on your gut, your tolerance, your starting point, and what is actually driving your inflammation.

This study is a useful reminder that there is no single right answer. All three approaches lowered inflammation. The strongest effects were from the most multi-mechanism intervention, which combined live cultures with fiber to feed them. That matches what I see clinically. The patients who do best are usually doing several small things that work together, not one big single-supplement push.

A few clinical nuances do come up. Inulin at 20 grams a day is a serious dose. People with SIBO, IBS, MCAS, or significant motility issues often cannot tolerate it without bloating, gas, or reactions. For those patients, starting with much lower doses, or with different fiber types altogether (partially hydrolyzed guar gum, soluble corn fiber, well-tolerated whole foods), is the more realistic move. Kefir similarly is well tolerated by some patients and a flare trigger for others, especially those with dairy sensitivity or histamine intolerance.

Omega-3 dosing in clinic almost always sits above 500 milligrams when we are working with an active inflammatory picture. The choice between EPA and DHA, the ratio, and the form (triglyceride versus ethyl ester) all factor in. This is one of the areas where individualization makes a measurable difference to patient response.

How to apply this now

1. If you are looking for foundational ways to support a calmer inflammatory baseline, think in terms of patterns rather than single supplements. Fiber from diverse plant foods, fermented foods you tolerate, and adequate omega-3 from food or supplementation all contribute.

2. Do not start a high-dose inulin regimen on your own if you have any history of gas, bloating, motility issues, IBS, SIBO, or MCAS. Build up slowly, and consider lower-FODMAP fibers as alternatives.

3. If you want to add a fermented food, start with one you tolerate well. Kefir, yogurt, miso, sauerkraut, kimchi, and natto all qualify. Listen to how your body responds. Some people do beautifully on dairy-based ferments; others need non-dairy options.

4. Omega-3 dose is one of the variables most patients get wrong. Most adults eating typical Western diets are under-supplied. Talk to a clinician about a dose that fits your situation, especially if you take blood thinners or have a bleeding tendency.

5. Pay attention to disclosures when you read nutrition research. The Vijay study openly disclosed that the kefir product was provided by co-authors. That does not invalidate the findings. It just means the synbiotic-wins framing needs to be held with proportional skepticism.

The bottom line for clinical practice is what it usually is. Test, treat, retest, individualize. A study like this one widens the menu of plausible interventions. The right one for you depends on what your gut, your symptoms, and your bloodwork are actually telling you.

References

1. Vijay A, Simpson L, Tooley M, et al. The anti-inflammatory effects of three different dietary supplement interventions. J Transl Med. 2025;23(1):1081. PMID: 41094562. doi:10.1186/s12967-025-07167-x.

Disclaimer

This article is for educational purposes only. It is not medical advice, does not create a clinician-patient relationship, and is not a substitute for individualized care from your own provider. Do not start or stop any supplement based on what you read here. People with inflammatory bowel disease, autoimmune conditions, MCAS, SIBO, or who take prescription medications should discuss any dietary supplement changes with their prescribing clinician.

---

If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.